FDA Approves First 'Biosimilar' Drug Zarxio Paving Way For More Affordable Drugs

The FDA has approved Zarxio, the first biosimilar drug in the U.S. More than 40 countries already use Zarxio to prevent infections in cancer patients receiving chemotherapy.